Literature DB >> 28865599

miR-206 enhances nasopharyngeal carcinoma radiosensitivity by targeting IGF1.

Tian Wang1, Xin-Min Dong1, Fu-Lin Zhang2, Ji-Ren Zhang3.   

Abstract

Radioresistance remains a major problem in nasopharyngeal carcinoma (NPC) treatment. However, the underlying molecular mechanisms of NPC radioresistance remain poorly understood. The present study aimed to investigate the potential role and mechanism of miR-206 in NPC radioresistance. We observed that miR-206 was down-regulated in radioresistant NPC cells. Furthermore, restoration of miR-206 in CNE2-IR cells suppressed enhanced radiosensitivity of NPC cells. In contrast, inhibition of miR-206 in CNE2 cells reduced the radiosensitivity. We also found that miR-206 directly targeted IGF1 and inhibited the PI3K/AKT pathway. Our data demonstrate that miR-206 sensitizes NPC cell to irradiation by targeting IGF1, highlighting the therapeutic potential of miR-206 in NPC radiosensitization.
Copyright © 2017. Published by Elsevier Taiwan.

Entities:  

Keywords:  IGF1; Nasopharyngeal carcinoma; PI3K/AKT pathway; Radioresistance; miR-206

Mesh:

Substances:

Year:  2017        PMID: 28865599     DOI: 10.1016/j.kjms.2017.05.015

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  10 in total

1.  Construction and analysis of miRNA-mRNA regulatory networks in the radioresistance of nasopharyngeal carcinoma.

Authors:  Houyu Zhao; Aoshuang Chang; Junjun Ling; Wei Zhou; Huiping Ye; Xianlu Zhuo
Journal:  3 Biotech       Date:  2020-11-07       Impact factor: 2.406

2.  miRNA Pattern in Hypoxic Microenvironment of Kidney Cancer-Role of PTEN.

Authors:  Aleksandra Majewska; Klaudia Brodaczewska; Aleksandra Filipiak-Duliban; Arkadiusz Kajdasz; Claudine Kieda
Journal:  Biomolecules       Date:  2022-05-11

3.  MicroRNA-372 enhances radiosensitivity while inhibiting cell invasion and metastasis in nasopharyngeal carcinoma through activating the PBK-dependent p53 signaling pathway.

Authors:  Zhe Wang; Ji-Wei Mao; Guang-Yan Liu; Fu-Guang Wang; Zai-Shuang Ju; Dong Zhou; Ruo-Yu Wang
Journal:  Cancer Med       Date:  2019-01-18       Impact factor: 4.452

4.  microRNA-613 exerts anti-angiogenic effect on nasopharyngeal carcinoma cells through inactivating the AKT signaling pathway by down-regulating FN1.

Authors:  Ru Gao; Qiaolei Feng; Guolin Tan
Journal:  Biosci Rep       Date:  2019-07-10       Impact factor: 3.840

5.  Prognostic Implication of Metabolic Syndrome in Patients with Nasopharyngeal Carcinoma: A Large Institution-Based Cohort Study from an Endemic Area.

Authors:  Shengyan Huang; Xirong Tan; Ping Feng; Sha Gong; Qingmei He; Xunhua Zhu; Na Liu; Yingqing Li
Journal:  Cancer Manag Res       Date:  2021-12-24       Impact factor: 3.989

6.  Key genes affecting the progression of nasopharyngeal carcinoma identified by RNA-sequencing and bioinformatic analysis.

Authors:  Yihong Wang; Manyi Li; Yan Guo; Haiping Huang; Xuelin Dong; Yangguang Sun; Jisheng Liu
Journal:  Aging (Albany NY)       Date:  2021-09-20       Impact factor: 5.682

7.  lncRNA cytoskeleton regulator reduces non‑small cell lung cancer radiosensitivity by downregulating miRNA‑206 and activating prothymosin α.

Authors:  Guoxiang Jiang; Honge Yu; Zhengliang Li; Fang Zhang
Journal:  Int J Oncol       Date:  2021-09-24       Impact factor: 5.650

Review 8.  Small biomarkers with massive impacts: PI3K/AKT/mTOR signalling and microRNA crosstalk regulate nasopharyngeal carcinoma.

Authors:  Hai-Long Li; Nian-Hua Deng; Xiu-Sheng He; Yue-Hua Li
Journal:  Biomark Res       Date:  2022-07-26

9.  Identification of non-invasive biomarkers for predicting the radiosensitivity of nasopharyngeal carcinoma from serum microRNAs.

Authors:  Kaiguo Li; Xiaodong Zhu; Ling Li; Ruiling Ning; Zhongguo Liang; Fanyan Zeng; Fang Su; Shiting Huang; Xiaohui Yang; Song Qu
Journal:  Sci Rep       Date:  2020-03-20       Impact factor: 4.379

10.  MicroRNA-195-3p inhibits cyclin dependent kinase 1 to induce radiosensitivity in nasopharyngeal carcinoma.

Authors:  Fuchuan Xie; Wei Xiao; Yunming Tian; Yuhong Lan; Chi Zhang; Li Bai
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.